Nanoparticle technology for drug delivery
暂无分享,去创建一个
[1] Gordon L. Amidon,et al. Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size , 1996, Pharmaceutical Research.
[2] D Needham,et al. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. , 1993, Cancer research.
[3] C. Lipinski. Poor aqueous solubility-an industry wide problem in drug discovery , 2002 .
[4] Ernesto Reverchon,et al. Nanomaterials and supercritical fluids , 2006 .
[5] Elaine Merisko-Liversidge,et al. Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] O'donnell,et al. Preparation of microspheres by the solvent evaporation technique. , 1997, Advanced drug delivery reviews.
[7] J Szebeni,et al. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.
[8] J. M. Shaw,et al. Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs , 1996, Pharmaceutical Research.
[9] Jae-Jin Shim,et al. Solubility in Supercritical Carbon Dioxide , 2006 .
[10] G. Liversidge,et al. The surface modified drug nanoparticles , 1992 .
[11] Indu Bala,et al. PLGA nanoparticles in drug delivery: the state of the art. , 2004, Critical reviews in therapeutic drug carrier systems.
[12] Christos Reppas,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.